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Desmosomes are essential adhesion structures in most
epithelia that link the intermediate ¢lament network of
one cell to its neighbor, thereby forming a strong bond.
The molecular components of desmosomes belong to
the cadherin superfamily, the plakin family, and the ar-
madillo repeat protein family.The desmosomal cadher-
ins are calcium-dependent transmembrane adhesion
molecules and comprise the desmogleins and desmo-
collins. To date, three human desmoglein isoforms have
been characterized, namely desmogleins 1, 2, and 3 that
are expressed in a tissue- and di¡erentiation-speci¢c
manner. Here we have identi¢ed and characterized, at
the genetic level, a novel human desmoglein cDNA
sharing homology with desmogleins 1, 2, 3 and we
name this desmoglein 4. The human desmoglein 4
cDNA (3.6 kb) contains an open reading frame of 3120
bp that encodes a precursor protein of 1040 amino acids.
The predicted mature protein comprises 991 amino
acids with a molecular weight of 107822 Da at pI 4.38.
Human desmoglein 4 shares 41% identity with human
desmoglein 1, 37% with human desmoglein 2, and 50%
with human desmoglein 3. Analysis of the exon/intron
organization of the human desmoglein 4 gene (DSG4)
demonstrates that it is composed of 16 exons spanning
approximately 37 kb of 18q12 and is situated between
DSG1 and DSG3. We have demonstrated using
RT-PCR on multiple tissue cDNA samples that desmo-
glein 4 has very speci¢c tissue expression in salivary
gland, testis, prostate, and skin. Keywords: Desmosome/
gene organization /desmosomopathy/pemphigus. J Invest Der-
matol 120:523 ^530, 2003
D
esmosomes are disc-like structures of 0.1^0.5 mm in
diameter and are located principally in epithelial
cells where they play a major role in cell-cell adhe-
sion as well as cell communication (Garrod, 1993;
Kouklis et al, 1994; Garrod, 1996; Green and Jones,
1996). Viewed under standard transmission electron microscopy
desmosomes present with a distinctive ultrastructure consisting
of two major domains. The ¢rst, termed the extracellular core
domain or ‘‘desmoglea’’, is approximately 30 nm in width and is
separated by an electron-dense mid line region. This extracellular
core domain consists of the extracellular heads of the desmoso-
mal cadherins that provide cellular adhesion to neighboring cells
(North et al, 1999). The second domain consists of an electron-
dense cytoplasmic plaque that can be further separated into an
outer dense plaque and an inner dense plaque, which are sepa-
rated from one another by an electron lucent zone. The cytoplas-
mic plaque is composed of the desmosomal plaque proteins
desmoplakin, plakoglobin, the plakophilins and the amino ter-
minal domains of the intermediate ¢lament proteins. Early stu-
dies on desmosomes identi¢ed a group of glycoproteins and
evidence suggested that they mediated the speci¢c recognition
and adhesion functions of desmosomes (Cohen et al, 1983).With
the resulting isolation and characterization of these glycoproteins
it was demonstrated that they were related to the calcium depen-
dent class of single pass transmembrane cell adhesion molecules,
the cadherins (Nilles et al, 1991) and were subsequently named
‘‘desmosomal cadherins’’.
Similar to the classical cadherins, the desmosomal cadherins
possess ¢ve homologous extracellular domains containing puta-
tive calcium-binding sites, a single transmembrane spanning do-
main, and a carboxy-terminal cytoplasmic tail (Wheeler et al,
1991). The cytoplasmic tails of the desmogleins and desmocollins
contain many motifs including an intracellular anchor domain
(IA), an intracellular cadherin-typical segment (ICS) and a major
binding site that contributes to the binding of the desmosomal
plaque protein, plakoglobin (Schmidt et al, 1994). The desmocol-
lins exist in ‘‘a’’ and ‘‘b’’ isoforms, the shorter ‘‘b’’ isoform lacking
the major binding site that eliminates its ability to bind plakoglo-
bin (Troyanovsky et al, 1993; Troyanovsky et al, 1994a;Troyanovs-
ky et al, 1994b). In addition, molecules in the desmoglein
subgroup contain a unique carboxy-terminal extension contain-
ing a ‘‘repeat unit domain’’ (RUD) that comprises a repeating
motif of approximately 29 amino acids (Koch et al, 1990;Wheeler
et al, 1991) that is predicted to form b-strands. In order to avoid
confusion the nomenclature was simpli¢ed by renaming the hu-
man proteins such that there were six desmocollins (i.e., 1a, 1b, 2a,
2b, 3a, and 3b), and three desmogleins (i.e., 1, 2, and 3) (Buxton
et al, 1993).
The largest desmosomal cadherins are desmocollin 2 and des-
moglein 2; they are the essential desmosomal cadherins common
to all desmosome-possessing tissues, including simple epithelia,
myocardium and many cell cultures (Koch et al, 1992; Theis et al,
1993; Schmidt et al, 1994). In contrast, the epidermal isoforms
desmocollins 1 and 3, and desmogleins 1 and 3 are restricted to
specialized epithelia, mostly strati¢ed squamous ones (Koch et al,
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1992; Schafer et al, 1994; Schmidt et al, 1994; Schafer et al, 1996).
Within the epidermis the three desmocollin/glein isoforms are
expressed in a di¡erentiation-speci¢c manner, with desmocollin
2 and desmoglein 2 being basal, desmoglein 3 and desmocollin
3 being basal layer and ¢rst suprabasal layer, and desmoglein 1
and desmocollin 1 being upper spinous and granular layer of epi-
dermis (Arnemann et al, 1993; King et al, 1993; Theis et al, 1993;
Schmidt et al, 1994; King et al, 1995; Nuber et al, 1995; Yue et al,
1995; Adams et al, 1998; Denning et al, 1998). In addition to its role
in cell adhesion in deep strati¢ed squamous epithelia, desmoglein
3 is also critical in anchoring the telogen hair to the outer root
sheath of the hair follicle and thus demonstrates that desmosomes
are important in maintaining the normal structure and function
of the hair (Koch et al, 1998).
The human desmoglein genes comprise either 15 or 16 exons
(Silos et al, 1996; Frank et al, 2001; Hunt et al, 2001) that are clus-
tered within a region of approximately 150 kb in the order 50 -
DSG1-DSG3-DSG2-30 (Simrak et al, 1995). The human desmo-
collin genes comprise 17 exons (Whittock et al, 2000b; Cserhal-
mi-Friedman et al, 2001), where exon 16 is alternatively spliced,
giving rise to the ‘‘a’’ and ‘‘b’’ forms of the protein (Collins et al,
1991; Greenwood et al, 1997). However, the genomic organization
of the desmocollin genes is closer to that of the classical cadherins
than the desmogleins (Greenwood et al, 1997). The entire DSC/
DSG gene complex occupies approximately 700 kb on 18q12.1,
and the genes are arranged in the order cen-30 -DSC3-DSC2-
DSC1-50 -50 -DSG1-DSG3-DSG2-30tel, where the two gene clus-
ters are transcribed outward from the interlocus region (Arnemann
et al, 1991; King et al, 1993; Cowley et al, 1997; Hunt et al, 1999).
Desmosome integrity is critical for normal cell-cell adhesion.
This is clearly highlighted in a group of disorders whereby de-
fects occur within desmosomal proteins that lead to the loss of
this adhesion. The genetic diseases of desmosomes cover a range
of disorders that can be inherited in autosomal dominant or re-
cessive modes and that can range from a¡ecting just palmoplantar
skin to those that a¡ect skin, hair and heart and can lead to death
during the second or third decade of life. In addition, desmoso-
mal proteins are targets for the autoimmune diseases pemphigus
vulgaris, pemphigus foliaceous and paraneoplastic pemphigus, as
well as substrates in staphylococcal scalded skin syndrome (SSSS).
Here we present the identi¢cation of an additional human des-
moglein which we term desmoglein 4 and demonstrate tissue
speci¢c expression. Based on gene structure and protein identity
we show that desmoglein 4 is closely related to desmoglein 3.
MATERIALS AND METHODS
Reverse transcription PCR (RT-PCR) and cDNA expression
studies Total RNA was extracted from normal skin biopsy using the
Perfect RNA kit (Eppendorf AG, Cambridge, UK) according to
manufacturer’s instructions. RNA was reverse transcribed using random
primers with the Thermo-script cDNA kit (Invitrogen Ltd, Paisley, UK)
according to the manufacturer’s instructions. Gene-speci¢c primers used
for overlapping RT-PCR of desmoglein 4 are available on request. Gene-
speci¢c intron crossing primers were designed for use in RT-PCR based
cDNA expression studies to exclude ampli¢cation of genomic DNA.
Primers used for desmoglein 4 were cDNA4F (forward-situated in exon
4) 50 -GTA GGG ATT GAT CGA CCA CC-30 and cDNA7R (reverse-
situated in exon 7) 50 -CTTGATTCTACAGTCACACTC-30 to yield a
507-bp product. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was ampli¢ed using the primers 50 -TGA AGG TCG GAG TCA ACG
GAT TTG GT-30 (forward) and 50 -CAT GTG GGC CAT GAG GTC
CAC CAC-30 (reverse). PCRwas performed in a 50-mL reaction mixture
containing 20 pmol forward and reverse primers, 10 nmol each of dTTP,
dCTP and dATP, 7.6 nmol dGTP, 2.5 nmol deaza GTP, 2.5 mL DMSO,
50 mmol betaine, 10 mM Tris^HCl, 50 mM KCl, 1.5 mM MgCl2 and
1.0 U Amplitaq Gold Taq polymerase (Applied Biosystems, Warrington,
UK). After an initial denaturation of 951C for 12 min, 40 cycles were
performed of 951C for 1 min, 551C for 1 min, and 721C for 2 min, with a
¢nal extension step of 721C for 10 min. The PCR products were examined
by 1.5% agarose gel electrophoresis, puri¢ed using spin columns (Qiagen,
Crawley, England) and directly sequenced using Big Dye terminators on
an ABI 377 genetic analyzer (Applied Biosystems) and analyzed using
Sequence Navigator 1.0.1. software (Applied Biosystems). To determine
the expression of desmoglein 4 a multiple tissue RNA panel II (adult)
(BD Clontech, Basingstoke, UK) was reverse transcribed and ampli¢ed as
described above.
RACE PCR The 50 and 30 ends of the desmoglein 4 cDNA were
isolated from skin and testis total RNA using the Smart Race
ampli¢cation kit (BD Clontech) according to the manufacturer’s
instructions. Primers used to amplify the 50 and 30 ends of desmoglein 4
were EX1B RACE 50 -CTG AAG AAG AGC CAATCC ATT CCT TTG
GG-30, and 3UTRRACEA 50 -GCA TCC CTT GAT ACT GTC TAA
CGA ATA GC-30. RACE PCR was performed using the Advantage II
PCR kit (BD Clontech) according to the manufacturer’s instructions, and
PCR products were puri¢ed and sequenced as above.
RESULTS
Sequence analysis reveals a novel human desmosomal
cadherin Analysis of the annotated human genome data
(http://genome.ucsc.edu) for chromosome 18 demonstrated
several predicted genes in the 100 kb gap between DSG1
and DSG3 using various algorithms. These included
ENST00000308128 (Ensembl), chr18.29.005.a and chr18.30.001.a
(Twinscan), and NT_010966.11 (Genescan). All of these predicted
genes demonstrated varying levels of homology with the known
desmoglein genes, DSG1-3. In addition, the predicted mRNA’s
and proteins showed a high level of homology to desmogleins
1^3. However, it was clear based on exon size conservation with
other DSG genes and amino acid sequence that the gene
prediction algorithms had incorrectly identi¢ed several exons
and most importantly had not correctly identi¢ed exon 1 and its
associated promoter. In order to locate exon 1, ¢ve regions
containing high homology with the syntenic mouse region
were identi¢ed as HumMus.18.14374, 14379, 14381, 14382, and
14383. Sequence analysis of HumMus.18.14374, 14379, 14382, and
14383 revealed no potential ¢rst exon; however, analysis of
HumMus.18.14381 revealed a region predicted to encode 16
amino acid residues with high homology to desmoglein 1
followed by a donor splice site. To determine whether these
predicted genes were indeed expressed in skin and to con¢rm
the correct exons, overlapping RT-PCRwas used on skin biopsy
total RNA from nonlesional skin. Sequence analysis of the
desmoglein 4 cDNA indicated a transcript of at least 3.6 kb
containing an open reading frame of 3120 bp (Fig 1). Exon/intron
organization revealed that the new gene, DSG4, comprised 16
exons spanning approximately 37 kb of human chromosome 18
with the entire desmoglein gene complex spanning
approximately 250 kb of 18q12 (Fig 2). The exons varied from
36 bp (exon 2) to 765 bp coding (exon 16) in size, and the
introns varied from 8176 bp (intron 1), to 153 bp (intron 13) in
size (Table 1). By gene structure alone DSG4 is more closely
related to DSG3 as they both consist of 16 exons whereas DSG1
and DSG2 comprise 15 exons (Table 2). In addition, the sizes
of exons for DSG3 and DSG4 are the same for exons 1, 2, 3, 4, 5,
6, 8, 9, 10, 13 and 14, demonstrating a high level of conservation
(Table 2).
Analysis of the deduced amino acid sequence of human
desmoglein 4 and comparison with the desmoglein
family The 3120 bp open reading frame of the human
desmoglein 4 cDNA encodes a precursor protein of 1040
residues with a predicted molecular weight of 113812 Da and
isoelectric point of 4.42 (Fig 1). This precursor comprises a 21
amino acid signal sequence followed by a 28 amino acid
prosequence that includes a NXS/T glycosylation site and ends
in a basic putative proteolysis sequence RRQKR. Cleavage
at this sequence would result in a mature desmoglein 4
unglycosylated peptide of 991 amino acids with a molecular
mass of 107822 Da and a pI of 4.38. The extracellular region of
desmoglein 4 (578 amino acids), by homology with other
desmogleins is divided into four domains of about equal size,
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EC1 to EC4 that have homology with each other, followed by an
extracellular anchor domain (EA).The highly conserved sequence
HAVof typical cadherins, which is thought to be involved in cell
adhesion, is represented in desmoglein 4 by the conservatively
substituted sequence RAL. Other conserved sequences in the
extracellular domains of desmoglein 4 and other desmogleins
with potential function include putative calcium binding motifs
(DXNDN and A/VXDXD). In addition, there are two further
potential N-glycosylation sites (NXS/T) in the extracellular
domain of desmoglein 4, in EC1 that is conserved in the
equivalent positions of desmogleins 1^3, and in EA that is
conserved only in desmoglein 3. The extracellular domain is
followed by a 25 amino acid predicted transmembrane domain.
The cytoplasmic domain of desmoglein 4 (388 amino acids)
comprises an intracellular anchor domain (IA), an intracellular
cadherin-typical segment (ICS), an intracellular linker domain
(LD), a repeat unit domain (RUD) and a terminal domain
(TD). The RUD domain contains one NVXVTE repeat and a
highly related NVIYAE predicting two repeats as found in
desmoglein 3. The overall protein identity of desmoglein 4 with
human desmoglein 1 (Nilles et al, 1991;Wheeler et al, 1991) is 41%,
with human desmoglein 2 (Koch et al, 1991; Arnemann et al, 1992)
is 37%, and human desmoglein 3 (Amagai et al, 1991) is 50%
(Table 3) (Fig 3). We therefore conclude that desmoglein 4 is a
member of the cadherin family and that it is more closely
related to the desmogleins than the typical cadherins.
Comparison of the individual regions for desmoglein 4 with
desmoglein 1, desmoglein 2 and desmoglein 3 demonstrates that
desmoglein 4 is more identical to desmoglein 1 over the
extracellular domain whereas it is more identical with
desmoglein 3 over the intracellular domain (Table 3).
RT-PCR on multiple tissue panel reveals tissue speci¢c
expression To determine whether the desmoglein 4 transcript
is expressed in other human tissues in addition to skin we
examined its tissue-speci¢c expression pro¢le using RT-PCR on
a cDNA panel derived from several adult tissues. The gene was
highly expressed in testis, prostate, and skin, but was less
abundant in salivary gland (Fig 4). No expression was detected
in thymus, uterus, skeletal muscle, thyroid, trachea, spleen, liver,
Figure1. Nucleotide and predicted amino acid sequence of human
desmoglein 4. Horizontal arrows under the amino acid sequence show
the beginning of each domain. The putative signal sequence is double
striked. The presumed recognition site for proteolytic cleavage (RRQKR)
is single striked. The RAL sequence, which corresponds to the HAV se-
quence of typical cadherins is underlined and boxed. Putative calcium
binding sites (DXNDN and A/VXDXD) are bold and underlined. The
transmembrane domain is underlined. The related NVXVTE repeats in
the repeat unit domain are bold and double-underlined. Potential N-gly-
cosylation sites are boxed. The translation initiation codon (ATG) is at nu-
cleotide position 1, and the predicted translation termination codon (TAA)
is marked with an asterisk (n). EC-extracellular domain, EA- extracellular
anchor domain, TM-transmembrane domain, IA-intracellular anchor do-
main, ICS-intracellular cadherin-typical segment domain, LD-linker do-
main, RUD-repeat unit domain,TD-terminal domain.
Figure 2. Predicted gene and protein details of human desmoglein
4. (a) Schematic representation of the human desmoglein complex. DSG4
lies between DSG1 and DSG3 with the entire desmoglein complex occu-
pying approximately 250 kb (b) Genomic organization of the human
DSG4. Exons are represented by vertical boxes, introns by horizontal lines.
The gene consists of 16 exons, spanning approximately 37 kb of genomic
DNA.The size of the individual exons and introns are presented inTable 1.
(c) The encoded protein, desmoglein 4, comprises a signal (S) and pre-
protein (p) domain followed by 5 extracellular domains (EC1-4, EA),
a transmembrane domain (TM), an intracellular anchor domain (IA),
an intracellular cadherin-typical segment domain (ICS), a linker domain
(LD), a repeat unit domain (RUD) containing two repeats, and a terminal
domain (TD).
HUMAN DESMOGLEIN 4 525VOL. 120, NO. 4 APRIL 2003
lung, placenta, fetal brain, heart, adrenal gland, bone marrow,
cerebellum, whole brain, or kidney.
GenBank accession number Human desmoglein 4 genomic
DNA and desmoglein 4 cDNA sequences have been deposited
in the GenBank sequence database under Accession Nos
AY177663 and AY177664, respectively.
DISCUSSION
Desmosomes are essential adhesion structures in most epithelia
and consist of a speci¢c subset of proteins necessary to attach the
intermediate ¢lament network of one cell to the intermediate
¢lament network of a neighboring cell, thus forming a strong
connection.
Table1. Exon-Intron Boundaries of the Human Desmoglein 4 Gene, DSG4
Exon Exon size (bp) 50 splice donor sequence Intron size (bp) 30 splice donor sequence
1 Non codingþ 48 CTAATGgtaagt 8176 aaacagGTGGTG
2 36 GTTGAGgtaatg 1516 cttaagGTGAAG
3 132 GCCAAAgtaagt 1547 ttatagATTCGA
4 156 TTCTTGgtaagt 351 ccacagATCTAT
5 145 ATGCCAgtaagt 1637 ttctagATACAT
6 167 AGAGAGgtaaag 255 attaagCAACAC
7 135 ACTTCAgtaagt 942 ttttagTACTCA
8 186 GTCAAGgtacag 6931 tttcagATGCTG
9 272 TGTCAGgtactg 1337 aaacagATATAT
10 140 TAGATGgtaaga 2395 tttcagATGGCT
11 219 CAAATGgtaagt 2442 tttcagCTACCT
12 297 TGATTTgtaagt 3078 gggcagTGGCTC
13 140 GACAGGgtaagt 153 tttcagGATGTG
14 64 CCTCTGgtcagt 1422 tgtcagCTTTTT
15 218 TCGGAGgtaatg 1379 ttttagAAAGCG
16 765þ non coding ND
Table 2. Comparison of the Deduced Exon Sizes for the Four Human Desmoglein Genes
Exon DSG1 DSG2 DSG3 DSG4
1 Non codingþ 48 Non codingþ 45 Non codingþ 48 Non codingþ 48
2 36 36 36 36
3 132 135 132 132
4 156 162 156 156
5 145 145 145 145
6 167 167 167 167
7 135 138 129 135
8 186 186 186 186
9 260 266 272 272
10 140 143 140 140
11 282 228 225 219
12 134 228 261 297
13 70 122 140 140
14 209 333 64 64
15 1047þ non coding 1020þ non coding 284 218
16 612þ non coding 765þ non coding
Table 3. Identity of the Desmoglein 4 Protein with Desmogleins 1^3
Domain Dsg4 vs. Dsg1 Dsg4 vs. Dsg2 Dsg4 vs. Dsg3
E1 82 (93) 64 (81) 70 (85)
E2 67 (82) 51 (67) 65 (81)
E3 50 (76) 50 (76) 67 (81)
E4 35 (59) 42 (60) 47 (72)
EA N/S 31 (53) 34 (54)
TM 52 (82) 64 (80) 75 (95)
IA 40 (60) N/S 49 (62)
ICS 53 (70) 43 (57) 58 (72)
LD N/S N/S N/S
RUD 39 (66) 30 (48) 51 (69)
TD 46 (67) N/S N/S
Entire protein 41 (56) 37 (53) 50 (66)
Values are expressed as a percentage (%).
Values in brackets are percentage similarity.
N/S ^ no signi¢cant identity or similarity.
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The amino-terminal domains of both the desmocollins and
desmogleins comprise the extracellular core domain of the
desmosome (North et al, 1999). However, the carboxy-terminal
domains of the desmosomal cadherins protrude into the outer
dense plaque at varying distances due to their di¡erent lengths.
The carboxy-terminal domains of the desmogleins reach at least
Figure 3. Multiple amino acid sequence alignment of human desmogleins 1^4. Horizontal arrows above the amino acid sequence show the begin-
ning of each domain. Desmoglein 1 (Nilles et al, 1991), desmoglein 2 (Koch et al, 1991), and desmoglein 3 (Amagai et al, 1991) are from published sequences.
Conserved amino acids are represented by asterisks (n) under the sequence. For abbreviations see Figure 1 legend.
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the inner edge of the outer dense plaque approximately 20 nm
from the plasma membrane and may even reach into the inner
dense plaque.Within the desmosome the cytoplasmic tail of the
desmogleins bind the ‘arm’ repeat domain of plakoglobin (Troya-
novsky et al, 1993; Mathur et al, 1994; Troyanovsky et al, 1994a;
Troyanovsky et al, 1994b). Speci¢cally, ‘‘arm’’ repeats 1^3 and per-
haps repeat 4 are required for binding of desmoglein (Kapprell
et al, 1988; Ozawa et al, 1995; Troyanovsky et al, 1996; Wahl et al,
1996;Witcher et al, 1996; Andl and Stanley, 2001). The stoichiome-
try of binding between the desmosomal cadherins and plakoglo-
bin has been extensively studied. Initial reports indicated that the
cytoplasmic tail of desmocollins could bind one molecule of pla-
koglobin only, whereas the cytoplasmic tail of desmogleins could
bind 6^7 plakoglobin molecules (Kowalczyk et al, 1996; Witcher
et al, 1996). A recent study, however, has demonstrated that the
desmogleins bind no more than 2 plakoglobin molecules (Bannon
et al, 2001). Indeed it was demonstrated that desmogleins 2 and 3
bound only one molecule of plakoglobin, where as the di¡erentia-
tion speci¢c isoform, desmoglein 1, bound 2 molecules of plako-
globin. The authors suggest that the isoform speci¢c binding of
plakoglobin may exert control over processes related to dif-
ferentiation, junctional assembly and homeostasis in epithelia
(Bannon et al, 2001).
The requirement for functionally intact desmosomes has been
demonstrated with the characterization of a signi¢cant group of
inherited disorders caused by mutations in the genes of the des-
mosomal proteins. These disorders include the genetically hetero-
geneous autosomal dominant condition, striate palmoplantar
keratoderma, that can be caused by mutations in the desmosomal
cadherin, desmoglein 1, the constitutive desmosomal plaque
member desmoplakin, or the type II epidermal keratin, keratin 1
(Armstrong et al, 1999; Rickman et al, 1999;Whittock et al, 1999;
Hunt et al, 2001; Kljuic et al, 2003;Whittock et al, 2002a). Muta-
tions in the desmosomal plaque member plakophilin 1 can result
in an autosomal recessive condition characterized by ectodermal
dysplasia and skin fragility (McGrath et al, 1997; McGrath et al,
1999; Whittock et al, 2000a; Hamada et al, 2002), and more re-
cently, mutations in plakoglobin and desmoplakin have been
shown to underlie a group of autosomal recessive conditions in-
volving skin, hair and heart (McKoy et al, 2000; Norgett et al,
2000;Whittock et al, 2002b).
Indeed, the involvement of desmosomal proteins in human
disease does not end with inherited disorders, as desmoglein 1,
desmoglein 3, and desmoplakin are targets for the autoimmune
blistering diseases pemphigus foliaceous, pemphigus vulgaris,
and paraneoplastic pemphigus (Stanley et al, 1984; Labib et al,
1990; Amagai et al, 1991; Oursler et al, 1992; Joly et al, 1994;
Olague-Alcala et al, 1994; Emery et al, 1995; Lin et al, 1997a; Lin
et al, 1997b; Allen and Camisa, 2000; Lin et al, 2000). The extra-
cellular domain of desmoglein 1 is also the target of exfoliative
toxins ETA and ETB from Staphylococcal aureus that cause the
generalized skin blistering disease staphylococcal scalded skin
dyndrome (SSSS) (Melish and Glasgow, 1970; Melish et al, 1972;
Amagai et al, 2000; Amagai et al, 2002). It therefore follows that
mutations in other undiscovered desmosomal proteins may un-
derlie inherited disorders or themselves be targets for autoim-
mune blistering disease and microbial attack.
Using genetic analysis we have identi¢ed a novel human des-
moglein gene, desmoglein 4, sharing signi¢cant homology with
all cadherins, but most markedly with desmoglein 3. Like all
other members of the cadherin family, desmoglein 4 has a puta-
tive signal sequence and a well-conserved sequence of basic ami-
no acids that presumably serves as a signal for cleavage to a
mature protein, followed by ¢ve extracellular domains, of which
EC1, EC2, EC3, and EC4 show variable homology with each
other. Like the typical cadherins, EA shows minimal or no signif-
icant homology with the other extracellular domains. Near the
amino terminus of the mature protein, the area important for
homophilic binding in typical cadherins, desmoglein 4 shows
much greater identity to corresponding domains of desmoglein
1 than to those of desmogleins 2 and 3. Like desmoglein 1 and
desmoglein 3, desmoglein 4 has an RAL site in EC1 that corre-
sponds to the conserved HAV site in an equivalent position in
typical cadherins. Desmoglein 4 also has several conserved puta-
tive calcium binding domains with all cadherins as well as several
conserved N-glycosylation sites with desmoglein 1 and desmo-
glein 3. Amongst the desmoglein genes, the desmoglein 4 gene
is most similar to desmoglein 3, as both comprise 16 exons.
Expression studies using RT-PCR on a human cDNA panel
demonstrated weak expression of desmoglein 4 in salivary gland.
It has previously been shown using RNA protection assays that
only desmoglein 2, and not desmoglein 1 or desmoglein 3, is
expressed in the salivary gland (Schmidt et al, 1994). As well as
skin, the desmoglein 4 transcript is also highly expressed in testis
and prostate gland. Comparative data for the other desmoglein
isoforms is only available for prostate gland, which shows that
only desmoglein 2 is expressed (Schmidt et al, 1994). The tissue
speci¢c transcript expression of desmoglein 4 in testis and pros-
tate has added signi¢cance due to the fact that loss of heterozyg-
osity (LOH) at 18q is found in both testicular and prostate
cancers. The spectrum of genetic alterations in human cancer
a¡ect speci¢c genes that play crucial roles in a varied range of
cellular processes such as cell adhesion, signal transduction, devel-
opment, DNA-repair and di¡erentiation. Testicular germ cell
tumors (TGCT) are probably the most prevalent type of tumor
among adolescent and young adult males. Suggestive linkage be-
tween disease and genetic markers has been reported for several
chromosomes including loss of genetic material at 18q12-ter (al-
Jehani et al, 1995; Lothe et al, 1995; Ottesen et al, 1997; Looijenga
et al, 2000; Skotheim et al, 2001). Prostatic carcinoma is the most
common form of male cancer found in the Western world and
LOH has been found for at least two locations on 18q12-21
(Bostwick et al, 1998; Verma et al, 1999; Padalecki et al, 2000; Chu
et al, 2001;Yin et al, 2001). The role of cell-cell adhesion molecules
in cancer is well understood as mutations in E-cadherin underlie
di¡use gastric cancers and lobular breast cancers (Berx et al, 1998),
and in most cases, the mutations occur in combination with LOH
of the wild-type allele. Loss of heterozygosity has also been re-
ported at 18q12 in esophageal carcinomas as well as cancer of the
head and neck (Papadimitrakopoulou et al, 1998; Karkera
et al, 1999; Pack et al, 1999). It is therefore possible that mutations
in desmoglein 4 in combination with LOH may underlie some
forms of testicular or prostate cancer.
In summary, using genetic analysis of human genomic data we
have identi¢ed a novel member of the human desmoglein gene
family that demonstrates highest homology to desmoglein 3,
and using RT-PCR demonstrate that the transcript and presum-
ably its protein is expressed only in speci¢c tissues. Further work
is now required to con¢rm desmoglein 4 expression at the pro-
tein level and to identify in which cell layers desmoglein 4 is ex-
pressed. In addition, studies are required to determine whether
some cases of inherited disorders of desmosomes such as striate
Figure 4. Tissue speci¢c expression of human desmoglein 4. Intron
crossing primers for desmoglein 4 and GAPDH (control ^ not shown)
were used to amplify cDNA from a multiple adult human tissue panel
(BD Clontech). Speci¢c expression of desmoglein 4 was observed in sali-
vary gland, testis, prostate, and skin. The negative control consisted of no
cDNA.
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palmoplantar keratoderma are caused by mutations in desmogle-
in 4, to see whether desmoglein 4 is a target antigen of autoanti-
bodies in pemphigus vulgaris or pemphigus foliaceus, and to
determine whether the extracellular domain of desmoglein 4 is
cleaved by either or both exfoliative toxins A and B.
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